» Articles » PMID: 36899946

Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics

Overview
Journal Cells
Publisher MDPI
Date 2023 Mar 11
PMID 36899946
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer has become a global health hazard accounting for 10 million deaths in the year 2020. Although different treatment approaches have increased patient overall survival, treatment for advanced stages still suffers from poor clinical outcomes. The ever-increasing prevalence of cancer has led to a reanalysis of cellular and molecular events in the hope to identify and develop a cure for this multigenic disease. Autophagy, an evolutionary conserved catabolic process, eliminates protein aggregates and damaged organelles to maintain cellular homeostasis. Accumulating evidence has implicated the deregulation of autophagic pathways to be associated with various hallmarks of cancer. Autophagy exhibits both tumor-promoting and suppressive effects based on the tumor stage and grades. Majorly, it maintains the cancer microenvironment homeostasis by promoting viability and nutrient recycling under hypoxic and nutrient-deprived conditions. Recent investigations have discovered long non-coding RNAs (lncRNAs) as master regulators of autophagic gene expression. lncRNAs, by sequestering autophagy-related microRNAs, have been known to modulate various hallmarks of cancer, such as survival, proliferation, EMT, migration, invasion, angiogenesis, and metastasis. This review delineates the mechanistic role of various lncRNAs involved in modulating autophagy and their related proteins in different cancers.

Citing Articles

A novel lncRNA FLJ promotes castration resistance in prostate cancer through AR mediated autophagy.

Wu Y, Cheng S, Zhang T, Wang L, Li T, Zheng Y J Transl Med. 2025; 23(1):255.

PMID: 40033417 PMC: 11874752. DOI: 10.1186/s12967-025-06294-9.


Identification and validation of an m5C-related lncRNA signature for predicting prognosis and immune response in clear cell renal cell carcinoma.

Ao S, Liang L, Peng L, Yang R, Chen Z, Deng T Discov Oncol. 2025; 16(1):227.

PMID: 39987537 PMC: 11847763. DOI: 10.1007/s12672-025-01987-5.


A novel lncRNA FAM151B-DT regulates autophagy and degradation of aggregation prone proteins.

Renganathan A, Minaya M, Broder M, Alfradique-Dunham I, Moritz M, Bhagat R medRxiv. 2025; .

PMID: 39974060 PMC: 11838976. DOI: 10.1101/2025.01.22.25320997.


Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications.

Basu S, Nadhan R, Dhanasekaran D Cancers (Basel). 2025; 17(3).

PMID: 39941838 PMC: 11815776. DOI: 10.3390/cancers17030472.


Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management.

Kumar A, Yap K, BharathwajChetty B, Lyu J, Hegde M, Abbas M J Biomed Sci. 2024; 31(1):105.

PMID: 39716252 PMC: 11667983. DOI: 10.1186/s12929-024-01092-9.


References
1.
Zhang F, Chen Q, Chen P, Liu C, Wang H, Zhao L . The lncRNA CRNDE is regulated by E2F6 and sensitizes gastric cancer cells to chemotherapy by inhibiting autophagy. J Cancer. 2022; 13(10):3061-3072. PMC: 9414014. DOI: 10.7150/jca.65871. View

2.
Karimi P, Islami F, Anandasabapathy S, Freedman N, Kamangar F . Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23(5):700-13. PMC: 4019373. DOI: 10.1158/1055-9965.EPI-13-1057. View

3.
Shi J, Guo C, Li Y, Ma J . The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation. Cell Death Dis. 2022; 13(11):961. PMC: 9668904. DOI: 10.1038/s41419-022-05424-1. View

4.
Ningegowda R, Shivananju N, Rajendran P, Basappa , Rangappa K, Chinnathambi A . A novel 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivative inhibits tumor cell invasion and potentiates the apoptotic effect of TNFα by abrogating NF-κB activation cascade. Apoptosis. 2016; 22(1):145-157. DOI: 10.1007/s10495-016-1312-8. View

5.
Xian Z, Hu B, Wang T, Zeng J, Cai J, Zou Q . lncRNA UCA1 Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells Through miR-23b-3p/ZNF281 Axis. Onco Targets Ther. 2020; 13:7571-7583. PMC: 7402858. DOI: 10.2147/OTT.S258727. View